Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | 76,500 | 59,559 | 45,641 | 33,858 | 22,110 |
| Cost of Goods | 8,948 | 7,142 | 5,464 | 3,390 | 2,154 |
| Gross Profit | 67,552 | 52,417 | 40,177 | 30,468 | 19,956 |
| Operating Expenses | 47,886 | 49,874 | 45,854 | 44,603 | 42,004 |
| Operating Income | 20,614 | 2,685 | -5,213 | -13,745 | -21,894 |
| Interest Expense | 634 | 736 | 596 | 635 | 643 |
| Other Income | 124 | 269 | 1,470 | 1,565 | 2,374 |
| Pre-tax Income | 20,104 | 2,218 | -4,339 | -12,815 | -20,163 |
| Income Tax | 415 | -156 | -90 | -487 | -78 |
| Net Income Continuous | 19,689 | 2,374 | -4,249 | -12,328 | -20,085 |
| Net Income | $19,689 | $2,374 | $-4,249 | $-12,328 | $-20,085 |
| EPS Basic Total Ops | 0.13 | 0.02 | -0.03 | -0.08 | -0.14 |
| EPS Basic Continuous Ops | 0.13 | 0.02 | -0.03 | -0.08 | -0.14 |
| EPS Diluted Total Ops | 0.12 | 0.02 | -0.03 | -0.08 | -0.14 |
| EPS Diluted Continuous Ops | 0.11 | 0.02 | -0.03 | -0.08 | -0.14 |
| EBITDA(a) | $22,574 | $4,965 | $-3,924 | $-12,024 | $-20,634 |